Bacterial growth parameters
|
Carrying capacity (bacteria.mL-1) |
Nmax
|
2.76 x 109
|
- |
[28] |
BE growth rate (h-1) |
μmaxE
|
1.61 |
1.59–1.63 |
BT growth rate (h-1) |
μmaxT
|
1.51 |
1.49–1.53 |
BET growth rate (h-1) |
μmaxET
|
1.44 |
1.42–1.47 |
Phage parameters
|
Phage adsorption rate (phage-1.h-1) |
β |
2.3 x 10−10
|
2.1 x 10−10–2.7 x 10−10
|
Phage concentration at half saturation (phage.mL-1) |
P50 |
1.19 x 1010
|
1.02 x 1010–1.29 x 1010
|
Phage burst size (phage) |
δmax
|
50 |
43–54 |
Phage latent period (h) |
τ |
0.61 |
0.60–0.77 |
Transduction probability (phage-1) |
α |
1.19 x 10−8
|
1.11 x 10−8–1.31 x 10−8
|
Phage decay rate (h-1) |
γP
|
0* |
0–0.1 |
[50] |
Antibiotic parameters
|
Erythromycin decay rate (h-1) |
γE
|
0* |
0–0.1 |
[51] |
Tetracycline decay rate (h-1) |
γT
|
0* |
0–0.1 |
Erythromycin-induced death rate on BE
|
Max death rate (h-1) |
εmaxE,E
|
1.10 |
- |
This study |
Half maximal effective concentration (mg.L-1) |
EC50E,E
|
3.42 |
- |
Hill coefficient |
HE,E
|
0.67 |
- |
Erythromycin-induced death rate on BT
|
Max death rate (h-1) |
εmaxE,T
|
3.91 |
- |
Half maximal effective concentration (mg.L-1) |
EC50E,T
|
9.26 |
- |
Hill coefficient |
HE,T
|
0.22 |
- |
Erythromycin-induced death rate on BET
|
Max death rate (h-1) |
εmaxE,ET
|
0.95 |
- |
Half maximal effective concentration (mg.L-1) |
EC50E,ET
|
2.47 |
- |
Hill coefficient |
HE,ET
|
0.79 |
- |
Tetracycline-induced death rate on BE
|
Max death rate (h-1) |
εmaxT,E
|
5.40 |
- |
Half maximal effective concentration (mg.L-1) |
EC50T,E
|
81.43 |
- |
Hill coefficient |
HT,E
|
0.30 |
- |
Tetracycline-induced death rate on BT
|
Max death rate (h-1) |
εmaxT,T
|
1.66 |
- |
Half maximal effective concentration (mg.L-1) |
EC50T,T
|
7.27 |
- |
Hill coefficient |
HT,T
|
2.41 |
- |
Tetracycline-induced death rate on BET
|
Max death rate (h-1) |
εmaxT,ET
|
1.58 |
- |
Half maximal effective concentration (mg.L-1) |
EC50T,ET
|
4.42 |
- |
Hill coefficient |
HT,ET
|
1.70 |
- |